ANDEMBRY
As listed in the register: ANDEMBRY 200 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA
200 mg · solución inyectable
- Prescription only
- Blood, clotting and anaemia
- Active substance
- Garadacimab
- Used in
- Blood, clotting and anaemia
- Made by
- Csl Behring Gmbh
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (ANDEMBRY). It describes the substance, not this exact product.
Garadacimab-gxii is an inhibitor of activated FXII that binds to the catalytic domain of activated Factor XII (FXIIa and βFXIIa) and inhibits its catalytic activity.
FXII is the first factor activated in the contact activation pathway and initiates the inflammatory bradykinin-producing kallikrein-kinin system.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2025-06-30
Safety of the active substance
From the US prescribing label for the same active substance (ANDEMBRY). It describes the substance, not this exact product.
Most common adverse reactions (incidence ≥ 7%) are nasopharyngitis and abdominal pain.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
European UnionNo exact match for this strength and form
CanadaNo exact match for this strength and form
Netherlands2 matching products
SwitzerlandNo exact match for this strength and form
Details
| Made by | Csl Behring Gmbh |
|---|---|
| Active substance | Garadacimab |
| Used in | Blood, clotting and anaemia |
| Strength | 200 mg |
| Form | solución inyectable |
| Classification | B06AC07 · Blood, clotting and anaemia |
| Route | vía subcutánea |
| Marketed | Yes, according to the register |
| Additional monitoring ▼ | Yes — under additional monitoring (black triangle). Report suspected side effects. |
| Name in the register | ANDEMBRY 200 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA |
| Nº Registro | 1241885003 |
Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician
Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.